HOUSE DOCKET, NO. 990 FILED ON: 1/9/2009
HOUSE .
. . . . . . . . . . . . . . No. 2027
The Commonwealth of Massachusetts
_______________
PRESENTED BY:
Jennifer M. Callahan
_______________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the passage of the accompanying bill:
An Act relative to
gentamyci
n
pediatric risk notification.
_______________
PETITION OF:
|
Name:
|
District/Address:
|
|
Jennifer M. Callahan
|
18th Worcester
|
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 3884 OF 2007-2008.]
The Commonwealth of Massachusetts
_______________
In the Year Two Thousand and Nine
_______________
An Act relative to
gentamycin
pediatric risk notification.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
Chapter 111 of the General Laws is hereby amended by inserting after Section 220 the following section
:—
Section 221. Any medical professional prescribing the antibiotic
gentamycin
for pediatric patients shall be required to provide parental notification prior to prescribing the medication. The parental notification shall include the potential risks and side effects associated with the antibiotic, including
ototoxicity
,
nephrotoxicity
and neurotoxicity. Any medical professional prescribing
gentamycin
to a pediatric patient shall document in the patient’s medical records the medical risks and side effects associated with the medication, including
ototoxicity
,
nephrotoxicity
and neurotoxicity. Any pediatric patient who is prescribed
gentamycin
shall have periodic serum peak and trough
gentamycin
blood level tests to monitor the patient’s health. Any medical professional prescribing
gentamycin
to a pediatric patient shall notify the Massachusetts commission for the deaf and hard of hearing each time the antibiotic is prescribed.
